FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta

FDA Approves Udenyca (pegfilgrastim-cbqv), a Biosimilar to Neulasta Print this page REDWOOD CITY, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (NASDAQ: CHRS), today announced that the U.S. Food and Drug Administration (FDA) has approved Udenyca (pegfilgrastim-cbqv), the first pegfilgrastim biosimilar approved by both the FDA and the European Commission (EC) for patients… Read More »

Husband demands answers after his wife, 34, died of asthma attack outside locked ER doors

‘They killed her’: Husband demands answers after his wife, 34, died of a treatable asthma attack outside locked ER doors Laura Levis was 34 when she died of cardiac arrest after an asthma attack  She had walked to CHA Somerville Hospital  The first door she tried was locked and she collapsed before getting to the… Read More »